HTA58 Cost-Utility Analysis of Palivizumab to Prevent Respiratory Syncytial Virus Infections in the Dominican Republic

Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1487
https://www.valueinhealthjournal.com/article/S1098-3015(23)01587-5/fulltext
Title : HTA58 Cost-Utility Analysis of Palivizumab to Prevent Respiratory Syncytial Virus Infections in the Dominican Republic
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01587-5&doi=10.1016/j.jval.2023.03.1487
First page :
Section Title :
Open access? : No
Section Order : 10887
Categories :
Tags :
Regions :
ViH Article Tags :